City of Hope receives $25M gift from Argyros family

Advancing peritoneal oncology: Innovations in surgical strategies and research

Peritoneal metastases arise from gastrointestinal and gynecologic malignancies, leading to debilitating symptoms and poor prognoses. They remain one of the most challenging manifestations of advanced malignancies, often leading to significant morbidity and limited treatment options.

April 25, 2025

Vol.51 No.16

By Mustafa Raoof

City of Hope’s BMT program performs 20,000th transplant
49-year history creates 20,000 tomorrows

This year marks the 49th anniversary of the City of Hope bone marrow transplant program, which was conceived and developed by Ernest Beutler and Karl Blume in 1975, with help and inspiration from E. Donnall Thomas, the 1990 Nobel Laureate in Physiology and Medicine.

Hope Rugo named director of City of Hope’s Women’s Cancers Program

Hope S. Rugo has joined City of Hope to lead its Women’s Cancers Program throughout the organization and breast medical oncology division section.

April 18, 2025

Vol.51 No.15

Clinical Roundup

Researchers identify novel molecular target for pancreatic cancer

Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterologystudy published on April 8.

April 18, 2025

Vol.51 No.15

In Brief

Mark Cosentino to lead City of Hope’s new Kathleen and Robert Henderson Biorepository

Mark Cosentino has joined City of Hope as scientific director of the new Kathleen and Robert Henderson Biorepository, which is designed to be a best-in-class facility that collects and organizes tissue samples and other biological materials across City of Hope’s national system to further boost its cancer and other research.

April 11, 2025

Vol.51 No.14